Natural language processing charts transcriptome evolution to design combination cancer therapies
Jassim, A.; Nimmervoll, B. V.; Terranova, S.; Nathan, E.; Masih, K. E.; Ruff, L.; Duarte, M.; Cooper, E.; Hu, L. P.; Katyal, G.; Akhbari, M.; Gilbertson, R. J.; Terhune, C.; Balmus, G.; Jackson, S. P.; Filbin, M. G.; Hill, A.; Patrizi, A.; Dani, N.; Regev, A.; Lehtinen, M. K.; Gilbertson, R. J.
Show abstract
Combination treatment-the mainstay of cancer therapy-often fails because treatment interactions evoke complex resistance mechanisms that are hard to predict. Designing combination therapy to prevent treatment resistance is especially challenging for rare cancers. Here, we introduce REsistance through COntext DRift (RECODR): a computational pipeline that tracks how genes change their transcriptome context across cancer development and drug treatment conditions. By applying RECODR to a genetically modified mouse model of choroid plexus carcinoma-a rare brain tumour of young children-we identified patterns of transcriptome evolution, cellular heterogeneity and treatment targets that emerged as tumours were initiated and resisted combination treatment. This enabled the prediction of treatment resistance mechanisms and the design of highly effective therapeutic protocols that avoided treatment failure. RECODR can describe complex and dynamic changes in normal and diseased tissues that could be applied to multimodal data from a variety of settings, mitigating treatment resistance across cancers and other diseases.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Cell cycle alterations associate with a redistribution of mutation rates across chromosomal domains in human cancers 96%
- Cell lineage as a predictor of immune response in neuroblastoma 95%
- Cancer-associated fibroblast compositions change with breast cancer progression linking S100A4 and PDPN ratios with clinical outcome 95%
Similar papers in this journal
- Single-cell lineage and transcriptome reconstruction of metastatic cancer reveals selection of aggressive hybrid EMT states 96%
- B3GALT6 Promotes Dormant Breast Cancer Cell Survival and Recurrence by Enabling Heparan Sulfate-Mediated FGF Signaling 96%
- Systematic Elucidation and Pharmacological Targeting of Tumor-Infiltrating Regulatory T Cell Master Regulators 96%
Similar papers in this journal
- PAX3-FOXO1 drives targetable cell state-dependent metabolic vulnerabilities in rhabdomyosarcoma 96%
- Spatiotemporal profiling defines persistence and resistance dynamics during targeted treatment of melanoma 95%
- Quantitative in vivo analyses reveal a complex pharmacogenomic landscape in lung adenocarcinoma 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.